Cargando…

The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19

The pathogenesis of Coronavirus Disease 2019 (COVID-19) involves cytokine-driven recruitment and accumulation of inflammatory cells at sites of infection. These activated neutrophils, monocytes, and effector T cells are highly glycolytic and thus appear as [18]F-labeled fluorodeoxyglucose (FDG) avid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griffin, Matthew T., Werner, Thomas J., Alavi, Abass, Revheim, Mona-Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040919/ https://www.ncbi.nlm.nih.gov/pubmed/37008755 http://dx.doi.org/10.1140/epjp/s13360-023-03797-6

Ejemplares similares

FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

(18)F-FDG and (18)F-NaF PET/CT Global Assessment of Large Joint Inflammation and Bone Turnover in Rheumatoid Arthritis
por: Reddy, Natasha, et al.
Publicado: (2023)

The role of (18)F-FDG PET/CT in primary cutaneous lymphoma: an educational review
por: McDonald, Elysia O., et al.
Publicado: (2023)

Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not
por: Alavi, Abass, et al.
Publicado: (2022)

The critical role of FDG-PET/CT imaging in assessing systemic manifestations of COVID-19 infection
por: Alavi, Abass, et al.
Publicado: (2021)

(18)F-FDG-PET/CT in radiation therapy-induced parotid gland inflammation
por: Mouminah, Alaa, et al.
Publicado: (2020)

Imaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder
por: Mayer, Michael, et al.
Publicado: (2020)

The Role of FDG-PET in the Evaluation of Hidradenitis Suppurativa: A Systematic Review
por: Talasila, Sahithi, et al.
Publicado: (2023)

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Atherosclerosis Burdens in Diabetes Mellitus: Assessment by PET Imaging
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2022)

Emerging role of 18F-FDG PET/CT in Castleman disease: a review
por: Koa, Benjamin, et al.
Publicado: (2021)

NaF-PET Imaging of Atherosclerosis Burden
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

FDG PET/CT in carcinoma of unknown primary
por: Kwee, Thomas C., et al.
Publicado: (2009)

Aging and Cerebral Glucose Metabolism: (18)F-FDG-PET/CT Reveals Distinct Global and Regional Metabolic Changes in Healthy Patients
por: Subtirelu, Robert Christopher, et al.
Publicado: (2023)

PET-Based Imaging with (18)F-FDG and (18)F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders
por: Raynor, William Y., et al.
Publicado: (2021)

Volumetric parameters from [ (18)F]FDG PET/CT predicts survival in patients with high‐grade gastroenteropancreatic neuroendocrine neoplasms
por: Langen Stokmo, Henning, et al.
Publicado: (2022)

(64)Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors
por: Mirzaei, Siroos, et al.
Publicado: (2019)

(18)F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques
por: Johnsrud, Kjersti, et al.
Publicado: (2017)

Is Imaging Bacteria with PET a Realistic Option or an Illusion?
por: Singh, Shashi B., et al.
Publicado: (2023)

Sacroiliac Joint Asymmetry Regarding Inflammation and Bone Turnover: Assessment by FDG and NaF PET/CT
por: Al-Zaghal, Abdullah, et al.
Publicado: (2019)

Aducanumab-Related Amyloid-Related Imaging Abnormalities: Paean or Lament?
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2022)

Inter-reader agreement of (18)F-FDG PET/CT for the quantification of carotid artery plaque inflammation
por: Johnsrud, Kjersti, et al.
Publicado: (2020)

FDG-PET/CT of COVID-19 and Other Lung Infections
por: Eibschutz, Liesl S., et al.
Publicado: (2022)

A Pilot Study of FDG-PET/CT in Polycythemia Vera Using Global Analysis Techniques
por: Ayubcha, Cyrus, et al.
Publicado: (2020)

Neurological and Psychiatric Manifestations of Long COVID-19 and Their [(18)F]FDG PET Findings: A Review
por: Hameed, Rizwanullah, et al.
Publicado: (2023)

Role of FDG-PET/CT in Assessing the Correlation Between Blood Pressure and Myocardial Metabolic Uptake
por: Rojulpote, Chaitanya, et al.
Publicado: (2020)

Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors
por: Helgebostad, Rasmus, et al.
Publicado: (2022)

Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer
por: Baun, Christina, et al.
Publicado: (2018)

Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2022)

Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET
por: Promteangtrong, Chetsadaporn, et al.
Publicado: (2015)

Value of FDG PET/CT in the assessment of patients with colon cancer comparing to stand-alone CT
por: Akbari, Kaveh, et al.
Publicado: (2014)

Comparison of [(18)F]fluciclovine and [(18)F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
por: Stokke, Caroline, et al.
Publicado: (2022)

Re: Aducanumab-Related ARIA: Paean or Lament?
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Alzheimer’s Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects—Atherosclerosis for a Start
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2022)

FDG PET/CT and Dosimetric Studies of (177)Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma—Are We Hitting the Target?
por: Løndalen, Ayca, et al.
Publicado: (2022)

Functional imaging of the interaction between gut microbiota and the human host: A proof-of-concept clinical study evaluating novel use for 18F-FDG PET-CT
por: Boursi, Ben, et al.
Publicado: (2018)

Monitoring the Effect of Targeted Therapies in a Gastrointestinal Stromal Tumor Xenograft Using a Clinical PET/CT
por: Revheim, Mona-Elisabeth, et al.
Publicado: (2010)

FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of (177)Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
por: Løndalen, Ayca, et al.
Publicado: (2020)

The Values and Limitations of FDG-PET/CT for Diagnosis of Hibernoma
por: Park, Jong Hoon, et al.
Publicado: (2015)

The Added Value of [(18)F]FDG PET/CT in the Management of Invasive Fungal Infections
por: Ankrah, Alfred O., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0g8j7q5982jr3cjbc5t9lg8g2q